Literature DB >> 27657666

Hierarchical group testing for multiple infections.

Peijie Hou1, Joshua M Tebbs1, Christopher R Bilder2, Christopher S McMahan3.   

Abstract

Group testing, where individuals are tested initially in pools, is widely used to screen a large number of individuals for rare diseases. Triggered by the recent development of assays that detect multiple infections at once, screening programs now involve testing individuals in pools for multiple infections simultaneously. Tebbs, McMahan, and Bilder (2013, Biometrics) recently evaluated the performance of a two-stage hierarchical algorithm used to screen for chlamydia and gonorrhea as part of the Infertility Prevention Project in the United States. In this article, we generalize this work to accommodate a larger number of stages. To derive the operating characteristics of higher-stage hierarchical algorithms with more than one infection, we view the pool decoding process as a time-inhomogeneous, finite-state Markov chain. Taking this conceptualization enables us to derive closed-form expressions for the expected number of tests and classification accuracy rates in terms of transition probability matrices. When applied to chlamydia and gonorrhea testing data from four states (Region X of the United States Department of Health and Human Services), higher-stage hierarchical algorithms provide, on average, an estimated 11% reduction in the number of tests when compared to two-stage algorithms. For applications with rarer infections, we show theoretically that this percentage reduction can be much larger.
© 2016, The International Biometric Society.

Entities:  

Keywords:  Case identification; Markov chain; Pooled testing; Screening; Sensitivity; Specificity

Mesh:

Year:  2016        PMID: 27657666      PMCID: PMC5362369          DOI: 10.1111/biom.12589

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  18 in total

1.  Maximally efficient two-stage screening.

Authors:  T Berger; J W Mandell; P Subrahmanya
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

2.  A cautionary note on the robustness of latent class models for estimating diagnostic error without a gold standard.

Authors:  Paul S Albert; Lori E Dodd
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

3.  Performance of the Abbott RealTime CT/NG for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  C A Gaydos; C P Cartwright; P Colaninno; J Welsch; J Holden; S Y Ho; E M Webb; C Anderson; R Bertuzis; L Zhang; T Miller; G Leckie; K Abravaya; J Robinson
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

4.  Reader reaction: A note on the evaluation of group testing algorithms in the presence of misclassification.

Authors:  Yaakov Malinovsky; Paul S Albert; Anindya Roy
Journal:  Biometrics       Date:  2015-09-22       Impact factor: 2.571

5.  Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system.

Authors:  Yosh Ohhashi; Anuradha Pai; Harkanwal Halait; Rainer Ziermann
Journal:  J Virol Methods       Date:  2010-02-10       Impact factor: 2.014

6.  Two-stage hierarchical group testing for multiple infections with application to the infertility prevention project.

Authors:  Joshua M Tebbs; Christopher S McMahan; Christopher R Bilder
Journal:  Biometrics       Date:  2013-10-04       Impact factor: 2.571

7.  Cost savings and increased efficiency using a stratified specimen pooling strategy for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Joanna Lynn Lewis; Vivian Marie Lockary; Sadika Kobic
Journal:  Sex Transm Dis       Date:  2012-01       Impact factor: 2.830

8.  Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System.

Authors:  Xinglong Xiao; Jianxin Zhai; Jinfeng Zeng; Cong Tian; Hui Wu; Yigang Yu
Journal:  J Virol Methods       Date:  2012-11-08       Impact factor: 2.014

9.  Pooled-testing procedures for screening high volume clinical specimens in heterogeneous populations.

Authors:  Christopher R Bilder; Joshua M Tebbs
Journal:  Stat Med       Date:  2012-03-13       Impact factor: 2.373

10.  Three-dimensional array-based group testing algorithms.

Authors:  Hae-Young Kim; Michael G Hudgens
Journal:  Biometrics       Date:  2008-11-13       Impact factor: 2.571

View more
  4 in total

1.  Nested Group Testing Procedure.

Authors:  Wenjun Xiong; Juan Ding; Wei Zhang; Aiyi Liu; Qizhai Li
Journal:  Commun Math Stat       Date:  2022-10-01

2.  Simulation of group testing scenarios can boost COVID-19 screening power.

Authors:  Vinicius Henrique da Silva; Carolina Purcell Goes; Priscila Anchieta Trevisoli; Raquel Lello; Luan Gaspar Clemente; Talita Bonato de Almeida; Juliana Petrini; Luiz Lehmann Coutinho
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

3.  Array testing for multiplex assays.

Authors:  Peijie Hou; Joshua M Tebbs; Dewei Wang; Christopher S McMahan; Christopher R Bilder
Journal:  Biostatistics       Date:  2020-07-01       Impact factor: 5.899

4.  Nonparametric estimation of distributions and diagnostic accuracy based on group-tested results with differential misclassification.

Authors:  Wei Zhang; Aiyi Liu; Qizhai Li; Paul S Albert
Journal:  Biometrics       Date:  2020-03-05       Impact factor: 1.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.